A
Ancuta Jurj
Researcher at Iuliu Hațieganu University of Medicine and Pharmacy
Publications - 71
Citations - 1361
Ancuta Jurj is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 17, co-authored 59 publications receiving 834 citations.
Papers
More filters
Journal ArticleDOI
The new era of nanotechnology, an alternative to change cancer treatment.
Ancuta Jurj,Cornelia Braicu,Laura-Ancuta Pop,Ciprian Tomuleasa,Claudia Gherman,Ioana Berindan-Neagoe +5 more
TL;DR: The background that supports the use of nanoparticles conjugated with different types of therapeutic agents, applicable in targeted therapy and cancer research, is highlighted, with a special emphasis on hematological malignancies.
Journal ArticleDOI
A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells.
Ancuta Jurj,Oana Zanoaga,Cornelia Braicu,Vladimir Lazar,Ciprian Tomuleasa,Alexandru Irimie,Ioana Berindan-Neagoe +6 more
TL;DR: A comprehensive understanding of the biophysical properties and physiological functions of EVs, their implications in TME, and the applicability of EVs for the development of cancer diagnostics and therapeutics are provided.
Journal ArticleDOI
Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.
Florin Zaharie,Mihai-Stefan Muresan,Bobe Petrushev,Cristian Berce,Grigore-Aristide Gafencu,Sonia Selicean,Ancuta Jurj,Roxana Cojocneanu-Petric,Cosmin-Ioan Lisencu,Laura-Ancuta Pop,Valentina Pileczki,Dan Tudor Eniu,Mihai-Andrei Muresan,Roxana Zaharie,Ioana Berindan-Neagoe,Ciprian Tomuleasa,Alexandru Irimie +16 more
TL;DR: New data are brought to the forefront that suggest miR-375 as a new player in controlling the pathways responsible for inhibiting the natural history of CRC tumor cells, via the Bcl-2 pathway.
Journal ArticleDOI
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.
Diana Gulei,Lorand Magdo,Ancuta Jurj,Lajos Raduly,Lajos Raduly,Roxana Cojocneanu-Petric,Alin Moldovan,Cristian Moldovan,Adrian Florea,Sergiu Pasca,Laura-Ancuta Pop,Vlad Moisoiu,Liviuta Budisan,Cecilia Pop-Bica,Cristina Ciocan,Rares Buiga,Mihai-Stefan Muresan,Rares Stiufiuc,Calin Ionescu,Ioana Berindan-Neagoe +19 more
TL;DR: The proposed strategy is aiming towards inhibition of metastasis and limitation of the tumor borders in advanced stages patients in order to prolong the survival time and to increase the efficiency of the current therapeutic strategies.
Journal ArticleDOI
Progress in Research on the Role of Flavonoids in Lung Cancer.
TL;DR: The purpose of this review was to summarize the current state of knowledge regarding relevant molecular mechanisms involved in the pharmacological effects, with a special focus on the anti-cancer role, by regulating the coding and non-coding genes.